These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 6109080

  • 21. Dopamine agonists in the treatment of Parkinson's disease.
    Rinne UK.
    Adv Neurol; 1983; 37():141-50. PubMed ID: 6305175
    [Abstract] [Full Text] [Related]

  • 22. Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
    Comet R, Domingo C, Such JJ, Ribera G, Sans J, Marín A.
    Respir Med; 1998 Sep; 92(9):1172-4. PubMed ID: 9926176
    [No Abstract] [Full Text] [Related]

  • 23. Treatment of parkinson's disease with bromocriptine.
    Lieberman A, Kupersmith M, Estey E, Goldstein M.
    N Engl J Med; 1976 Dec 16; 295(25):1400-4. PubMed ID: 989885
    [Abstract] [Full Text] [Related]

  • 24. Pleuropulmonary reactions in patients on bromocriptine treatment.
    Tornling G, Unge G, Axelsson G, Noring L, Granerus AK.
    Eur J Respir Dis; 1986 Jan 16; 68(1):35-8. PubMed ID: 3948932
    [Abstract] [Full Text] [Related]

  • 25. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial.
    Olsson JE.
    Adv Neurol; 1990 Jan 16; 53():421-3. PubMed ID: 2239483
    [No Abstract] [Full Text] [Related]

  • 26. Bromocriptine in Parkinson's disease.
    Stern G, Lees A.
    Br J Hosp Med; 1978 Dec 16; 20(6):666-70. PubMed ID: 743580
    [No Abstract] [Full Text] [Related]

  • 27. [A comparative study of the effect of bromocriptine and pergolide on Parkinson disease].
    de Yébenes JG, García-Ruiz PJ, Sánchez-Pernaute R.
    Rev Neurol; 1997 Sep 16; 25(145):1343-5. PubMed ID: 9377286
    [Abstract] [Full Text] [Related]

  • 28. Bromocriptine and pleuropulmonary disease.
    Melmed S, Braunstein GD.
    Arch Intern Med; 1989 Feb 16; 149(2):258-9. PubMed ID: 2916870
    [No Abstract] [Full Text] [Related]

  • 29. [Pleuropulmonary changes during treatment with bromocriptine].
    Ugeskr Laeger; 1988 May 02; 150(18):1124. PubMed ID: 3368987
    [No Abstract] [Full Text] [Related]

  • 30. Long-term effects of bromocriptine given to de novo patients with idiopathic Parkinson's disease.
    Stern G, Lees A.
    Adv Neurol; 1987 May 02; 45():525-7. PubMed ID: 3103395
    [No Abstract] [Full Text] [Related]

  • 31. [Comparison of bromocriptine and levodopa as first line treatment of Parkinson's disease: results of a 3-year prospective randomized study].
    Montastruc JL, Rascol O, Rascol A.
    Rev Neurol (Paris); 1990 May 02; 146(2):144-7. PubMed ID: 2181588
    [Abstract] [Full Text] [Related]

  • 32. Levodopa compared with bromocriptine in the treatment of Parkinson's disease.
    Godwin-Austen RB.
    Adv Biochem Psychopharmacol; 1980 May 02; 23():261-5. PubMed ID: 7395616
    [No Abstract] [Full Text] [Related]

  • 33. Adjunctive therapy with bromocriptine in Parkinson's disease.
    Temlett JA, Ming A, Saling M, Fritz VU, Blumenfeld A, Bilchik TR, Becker AL, Fourie PB, Reef HE.
    S Afr Med J; 1990 Dec 01; 78(11):680-5. PubMed ID: 2251616
    [Abstract] [Full Text] [Related]

  • 34. An evaluation of bromocriptine in the treatment of Parkinson's disease.
    Mackenzie RA, Lance JW.
    Clin Exp Neurol; 1978 Dec 01; 15():228-36. PubMed ID: 386307
    [Abstract] [Full Text] [Related]

  • 35. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA, Przuntek H, Majer M, Welzel D.
    Dtsch Med Wochenschr; 1984 Aug 24; 109(34):1279-83. PubMed ID: 6381019
    [Abstract] [Full Text] [Related]

  • 36. The role of bromocriptine in the treatment of Parkinson's disease.
    Stern GM, Lees AJ, Shaw KM, Lander CM.
    Adv Biochem Psychopharmacol; 1980 Aug 24; 23():267-70. PubMed ID: 7395617
    [No Abstract] [Full Text] [Related]

  • 37. Bromocriptine mesylate in Parkinson's disease.
    Lieberman A, Kupersmith M, Neophytides A, Casson I, Durso R, Foo SH, Khayali M, Tartaro T.
    N Y State J Med; 1979 Oct 24; 79(11):1689-92. PubMed ID: 290866
    [No Abstract] [Full Text] [Related]

  • 38. Low-dose bromocriptine in the early phases of Parkinson's disease.
    Tolosa E, Blesa R, Bayes A, Forcadell F.
    Clin Neuropharmacol; 1987 Apr 24; 10(2):168-74. PubMed ID: 3332610
    [Abstract] [Full Text] [Related]

  • 39. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A, Grau-Veciana JM.
    Med Clin (Barc); 1985 Jun 15; 85(3):88-91. PubMed ID: 4021630
    [No Abstract] [Full Text] [Related]

  • 40. Long-term treatment with high-dosage bromocriptine in advanced Parkinson's disease.
    Jansen EN, Meerwaldt JD.
    Adv Neurol; 1987 Jun 15; 45():539-42. PubMed ID: 3103396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.